Notably, before starting emapalumab treatment the child had developed several infections (disseminated BCGitis, adenoviral infection, Stenotrophomonas maltophilia bacteremia, invasive pulmonary aspergillosis) which did not worsen with IFNγ blockade. Here, IFNG is linked to infection.